In General You Do Not Have To Be Everolimus Addicted To Get Stung

Blood transfusion was also identified as a possible mode of transmission (6%); however, 24% of the infected individuals did not have a known risk factor (209). In another study, IDU was also reported as the main risk factor (28%) among a group of 51 HCV patients referred for possible liver transplantation (210). The few studies in Norway reported a prevalence of http://www.selleckchem.com/products/ch5424802.html essential for determining the overall prevalence in the country, it is important to note that active drug users are less likely to participate in health surveys, which may result in rates that are lower than the actual national average. In Norway, the http://www.selleckchem.com/products/azd9291.html prevalence of IDU is near the median for countries reporting to the European Monitoring Centre for Drugs and Drug Addiction (136). Specific groups such as IDUs have been studied by researchers and report values that are substantially higher than the general population, ranging from 56 to 93% depending on the year (216, 217). Other groups such as pregnant women have been studied and prevalence rates similar to that of the general population Oslo Health Study have been reported (213). One blood donor study has been reported that yielded a rate much lower than that of the general population (0.11% compared with 0.70%) (214). Incidence rates as reported to the ECDC are similar to the low prevalence rates reported previously. These have ranged from 0.4 to 0.8 cases per 100?000 people from 1996 to 2005 (10). However, it is believed that the reported rates are underestimating the actual incidence rate. Given that the size of the HCV prevalent population is approximately 30?000 individuals and the viral epidemic reached Norway 40 years ago, there are approximately 10�C20 cases per 100?000 persons per year (218). The most representative study for http://www.selleck.cn/products/Everolimus(RAD001).html genotype distribution comes from the Oslo Health Study. In this study, the most common genotype identified from a community sample was genotype 1 (61.5%); both subtypes 1a and 1b were represented equally (28%). Genotype 3a was also a commonly identified genotype, in 28% of patients, and genotype 2b in 10.5% of patients (209). Another researcher found genotype 3 to be the most common (50%). However, this study consisted mainly of IDUs, which may explain the difference in the genotype distribution between the two studies (219). Hepatitis C virus prevalence is relatively low in Norway, estimated to be